Volume : 12, Issue : 10, October – 2025

Title:

FORMULATION AND EVALUATION OF EXTENDED-RELEASE MATRIX TABLETS OF SALBUTAMOL SULPHATE USING NATURAL POLYMERS

Authors :

Aafia Fatima,Alisha Ishrath, Dr.Syed Areefulla Hussainy, Dr.Abdul Sayeed

Abstract :

The present study involves the formulation and evaluation of extended release matrix tablets of Salbutamol Sulphate using natural polymers such as Guar Gum, Locust Bean Gum, and Gum Damar. The primary objective was to develop a sustained release formulation that could maintain therapeutic drug levels over an extended period, thereby reducing dosing frequency and improving patient compliance. A total of nine formulations were prepared using varying concentrations of the selected natural polymers. All formulations were subjected to pre- compression and post-compression evaluations, and the results were found to be within the acceptable limits as per IP standards. Among all, formulation F6 was identified as the optimized batch, as it exhibited the most desirable drug release profile, achieving 99.08% drug release over 12 hours. The study concludes that natural polymers can effectively be used in the formulation of extended release tablets of Salbutamol Sulphate, offering a promising and sustainable alternative to synthetic polymers in controlled drug delivery systems.
Keywords: Salbutamol Sulphate, Locust Bean Gum, Guar Gum and Gum Damar

Cite This Article:

Please cite this article in press Aafia Fatima et al., Formulation And Evaluation Of Extended-Release Matrix Tablets Of Salbutamol Sulphate Using Natural Polymers, Indo Am. J. P. Sci, 2025; 12(10).

REFERENCES:

1. Altaf AS, Friend DR, MASRx and COSRx. Sustained-Release Technology in Rathbone MJ, Hadgraft J, Robert MS, Modified Release Drug Delivery Technology, Marcell Dekker Inc., New York, 2003; 1: 102-117.
2. Reddy KR., Mutalik S, Reddy S. AAPS Pharm. Sci. Tech.2003; 4: 19. 121-125.
3. Mohammed AD et al. Release of propranolol hydrochloride from matrix tablets containing sodium carboxymethylcellulose and Hydroxypropyl methyl cellulose. Pharm Dev Tech.1999; 4: 313-324.
4. Salsa T, Veiga F. Drug Develop. Ind Pharm. 1997; 23: 931.
5. Jantzen GM, Robinson JR, Sustained and controlled-release drug delivery systems, inBanker GS, Rhodes CT (Eds.) Modern Pharmaceutics, 3rd Ed, Revised andExpanded, Drugs and the Pharmaceutical Sciences., Marcell Dekker, Inc. NewYork. 1995; 72: 575-609.
6. Jantzen GM, Robinson JR. Sustained and Controlled- Release Drug Delivery systems Modern Pharmaceutics, 4thed; 2003; 121: 501-502.
7. Lee BJ, Ryu SG, Cui JH, Drug Dev. Ind.Pharm.1999; 25: 493-501.
8. Gwen MJ, Joseph RR, In Banker GS and Rhodes CT, Ed. Modern Pharmaceutics, 3rdEd Marcel Dekker Inc. New York. 1996; 72: 575.
9. Vidyadhara S, Rao PR, Prasad JA. Indian J Pharm Sci. 2004; 66: 188-192.
10. Bogner RH. Bioavailability and bioequivalence of extended-release oral dosage forms. US Pharmacist. 1997; 22: 3–12.
11. Rogers JD, Kwan KC. Pharmacokinetic requirements for controlled-release dosage forms. In: John Urquhart, ed. Controlled-release Pharmaceuticals. Academy of Pharmaceutical Sciences. American Pharmaceutical Association. 1979: 95–119.
12. Madan PL. Sustained-release drug delivery systems, part II: Preformulation considerations. Pharm Manu fact. 1985; 2: 41–45.
13. Wani MS, Controlled Release System-A Review, 2008; 6 1: 56-62.
14. Banker GS, Anderson NR. The Theory and Practice of Industrial Pharmacy: Tablet,Lachman, (3rded) Varghese Publishing House, Bombay. 1990; 3: 293-303.
15. Lee VHL, Controlled Drug Delivery Fundamentals and Applications: Influence of drug properties on design, Marcel Dekker, INC, and New York. 1987; 2: 16-29.
16. Manish R, Jayesh P, Siahboomi AR. Hydrophilic Matrices for Oral Extended Release: Influence of Fillers on Drug Release from HPMC Matrices. Pharma Times. 2010; 42(04): 67- 73.
17. Kumar KP et al. Innovations in Sustained Release Drug Delivery System and Its Market Opportunities. J ChemPharm Res. 2010; 2 1: 349-360.
18. Brahmankar DM, Sunil B. Jaishwal. “Controlled release medication” chapter 15th in “Bio pharmaceutics and Pharmacokinetics – A Treatise, 1st ed, 2010; 1: 347- 353.
19. Stanley S. Davis, Formulation strategies for abs windows. Drug Discovery Today, 2005; 10:249-257.
20. Modi SA et al. Sustained Release Drug Delivery System:A Review.Int J Pharma. Res Dev. 2011; 2 (12): 147-160.
21. Lieberman HA, Lachman L, Schwartz JB., Pharmaceutical Dosage Forms: Tablets, 2011; 3 (2): 199-287.
22. Aulton ME. Pharmaceutics: The Science of Dosage Form Design. 2005; 2: 296-298.
23. Wise DL. Handbook of Pharmaceutical Controlled Release Technology. Inc. 2005; 2: 5-24.
24. Jantzen GM, Robinson JR. Sustained and Controlled- Release Drug Delivery systems Modern Pharmaceutics, 4thed; 2011; 121: 501-502.
25. Subhash Chandra, Vijay Sharma, N. Ravindra, Sunil Kumawat. Formulation and Evaluation of Extended-Release Tablets of Ranolazine. International Journal of Health Advancement and Clinical Research (tz)2024; 2(1);8-14.
26. Ashish P. Gorle,Pradnya N. Oza, Rutuja S. Shende, Jayesh A. Mahirrao. Formulation, Development and Evaluation of Extended- Release Tablets of Carbamazepine. Research J. Pharm. and Tech 2023; 16(6):2808-2812.
27. Rapol Swathi, Dr. M. Sunitha Reddy, Appidi Vijay. Formulation and Evaluation of Extended-Release Tablets of Oxybutynin HCL by Push-Pull Technology. Saudi J Med Pharm Sci, Oct, 2022; 8(10): 493-501.
28. Divya, J. Sreekanth, D. Satyavati. Formulation and Evaluation of Extended Release Matrix Tablets of Tenatoprazole Sodium using Synthetic Polymers. J Young Pharm, 2020; 12(2) Suppl: s39-s44.
29. VivelBattu1 , S. Padma Priya, Formulation and Evaluation of Extended Release Matrix Tablets of Metoprolol Succinate Using Natural Polymers, Vol.9; Issue: 4;2019; International Journal of Health Sciences & Research.